PADCENS, the Philippine diabetes care nurse association, says it upholds ethical practice and patient safety. The excerpt never says what prompted it.
Recap by typeshit. Post by Facebook on Facebook.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Experts quoted by TODAY offer practical ways to ease one of the most common side effects people report on GLP-1 medications.
Late-stage trials show weight loss near 30%, with Phase 3 finishing in late 2026. Testing finds about 30% of gray-market peptide samples have problems.
Loading…